Breast Cancer Research and Treatment

Papers
(The H4-Index of Breast Cancer Research and Treatment is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Differential response of luminal and basal breast cancer cells to acute and chronic hypoxia138
Therapeutic impact of 18F-FDG PET/CT for initial staging in patients with clinical stage I and IIA, HER2-positive, or triple-negative breast cancer114
Cognitive effects of aromatase inhibitors in early breast cancer patients: a prospective study73
Alteration of PD-L1 (SP142) status after neoadjuvant chemotherapy and its clinical significance in triple-negative breast cancer66
The association between cirrhosis and outcomes among female patients undergoing surgery for breast cancer in Ontario: a population-based study56
Predicting the likelihood of carrying BRCA1 or BRCA2 pathogenic variants in high-risk Pakistani breast cancer patients48
Integrating SENOMAC and AMAROS: a call for de-escalation47
Impact of environmental temperature on the survival outcomes of breast cancer: A SEER-based study41
Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patients40
Correction: Timely cancer genetic counseling and testing for young women with breast cancer: impact on surgical decision-making for contralateral risk-reducing mastectomy39
Chronic inflammatory diseases and survival among breast cancer patients in the U.S. military health system38
Comparative efficacy and safety of extended adjuvant endocrine therapy for hormone receptor-positive early breast cancer: a Bayesian network meta-analysis35
Effect of metformin and lifestyle intervention on adipokines and hormones in breast cancer survivors: a pooled analysis from two randomized controlled trials35
Changes in expression of breast cancer tumor biomarkers between primary tumors and corresponding metastatic sites: common patterns and relationships with survival34
Cardiovascular adverse events associated with denosumab versus zoledronic acid in patients with breast cancer: a propensity score overlap weighted analysis32
A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer32
Temporal patterns of breast cancer incidence, mortality, disability-adjusted life years and risk factors in 12 South American Countries, 1990–2019: an examination using estimates from the global burde32
Assessing the accuracy of inflammatory breast cancer self-reported diagnoses through the metastatic breast cancer project from the count me in initiative database30
Risk of myocardial infarction and stroke after breast cancer: an analysis of a population of 1.3 million women from North-West Italy29
Intraoperative assessment of axillary sentinel lymph nodes by telepathology27
Kidney function changes associated with trastuzumab use in women with breast cancer: a retrospective cohort study27
Nuclear magnetic resonance-determined lipoprotein profile and risk of breast cancer: a Mendelian randomization study27
Premenopausal women with breast cancer in the early post-partum period show molecular profiles of invasion and are associated with poor prognosis26
Outcomes of male patients with HR+/HER2– advanced breast cancer receiving palbociclib in the real-world POLARIS study26
Omission of anthracyclines from neoadjuvant chemotherapy for breast cancer: a population-based analysis26
Inter-reader agreement of breast magnetic resonance imaging and contrast-enhanced mammography in breast cancer diagnosis: a multi-reader retrospective study26
0.16107416152954